Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.27
CNMD's Cash to Debt is ranked lower than
82% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. CNMD: 0.27 )
Ranked among companies with meaningful Cash to Debt only.
CNMD' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: No Debt
Current: 0.27
Equity to Asset 0.53
CNMD's Equity to Asset is ranked lower than
66% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. CNMD: 0.53 )
Ranked among companies with meaningful Equity to Asset only.
CNMD' s Equity to Asset Range Over the Past 10 Years
Min: 0.29  Med: 0.54 Max: 0.93
Current: 0.53
0.29
0.93
Interest Coverage 8.49
CNMD's Interest Coverage is ranked lower than
86% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. CNMD: 8.49 )
Ranked among companies with meaningful Interest Coverage only.
CNMD' s Interest Coverage Range Over the Past 10 Years
Min: 1.24  Med: 7.26 Max: 11.38
Current: 8.49
1.24
11.38
F-Score: 5
Z-Score: 2.84
M-Score: -2.56
WACC vs ROIC
7.27%
4.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.12
CNMD's Operating margin (%) is ranked higher than
64% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. CNMD: 7.12 )
Ranked among companies with meaningful Operating margin (%) only.
CNMD' s Operating margin (%) Range Over the Past 10 Years
Min: -0.71  Med: 7.71 Max: 11.67
Current: 7.12
-0.71
11.67
Net-margin (%) 4.24
CNMD's Net-margin (%) is ranked higher than
59% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. CNMD: 4.24 )
Ranked among companies with meaningful Net-margin (%) only.
CNMD' s Net-margin (%) Range Over the Past 10 Years
Min: -1.93  Med: 4.53 Max: 5.97
Current: 4.24
-1.93
5.97
ROE (%) 5.27
CNMD's ROE (%) is ranked higher than
57% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. CNMD: 5.27 )
Ranked among companies with meaningful ROE (%) only.
CNMD' s ROE (%) Range Over the Past 10 Years
Min: -2.8  Med: 5.67 Max: 8.77
Current: 5.27
-2.8
8.77
ROA (%) 2.78
CNMD's ROA (%) is ranked higher than
59% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. CNMD: 2.78 )
Ranked among companies with meaningful ROA (%) only.
CNMD' s ROA (%) Range Over the Past 10 Years
Min: -1.42  Med: 3.22 Max: 4.72
Current: 2.78
-1.42
4.72
ROC (Joel Greenblatt) (%) 15.26
CNMD's ROC (Joel Greenblatt) (%) is ranked higher than
65% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. CNMD: 15.26 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CNMD' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -1.79  Med: 15.95 Max: 26.66
Current: 15.26
-1.79
26.66
Revenue Growth (3Y)(%) 1.70
CNMD's Revenue Growth (3Y)(%) is ranked lower than
58% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. CNMD: 1.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CNMD' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.1  Med: 3.55 Max: 40.8
Current: 1.7
-0.1
40.8
EBITDA Growth (3Y)(%) 33.00
CNMD's EBITDA Growth (3Y)(%) is ranked higher than
90% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. CNMD: 33.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CNMD' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -35.8  Med: 3.95 Max: 43.5
Current: 33
-35.8
43.5
EPS Growth (3Y)(%) 254.60
CNMD's EPS Growth (3Y)(%) is ranked higher than
97% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. CNMD: 254.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CNMD' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -73.3  Med: 6.80 Max: 254.6
Current: 254.6
-73.3
254.6
» CNMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

CNMD Guru Trades in Q1 2015

Mario Gabelli 91,700 sh (unchged)
Paul Tudor Jones Sold Out
John Keeley Sold Out
Chuck Royce 81,500 sh (-0.85%)
Ken Fisher 393,394 sh (-3.03%)
» More
Q2 2015

CNMD Guru Trades in Q2 2015

Chuck Royce 81,500 sh (unchged)
Ken Fisher 391,394 sh (-0.51%)
Mario Gabelli 90,100 sh (-1.74%)
» More
Q3 2015

CNMD Guru Trades in Q3 2015

Paul Tudor Jones 6,500 sh (New)
Jim Simons 21,100 sh (New)
Chuck Royce 81,500 sh (unchged)
Mario Gabelli 89,800 sh (-0.33%)
Ken Fisher 387,933 sh (-0.88%)
» More
Q4 2015

CNMD Guru Trades in Q4 2015

Ken Fisher 386,705 sh (-0.32%)
Mario Gabelli 89,500 sh (-0.33%)
» More
» Details

Insider Trades

Latest Guru Trades with CNMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 29.71
CNMD's P/E(ttm) is ranked lower than
53% of the 251 Companies
in the Global Medical Devices industry.

( Industry Median: 26.20 vs. CNMD: 29.71 )
Ranked among companies with meaningful P/E(ttm) only.
CNMD' s P/E(ttm) Range Over the Past 10 Years
Min: 9.88  Med: 27.89 Max: 755.25
Current: 29.71
9.88
755.25
Forward P/E 22.03
CNMD's Forward P/E is ranked lower than
61% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 18.38 vs. CNMD: 22.03 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.71
CNMD's PE(NRI) is ranked lower than
54% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 27.11 vs. CNMD: 29.71 )
Ranked among companies with meaningful PE(NRI) only.
CNMD' s PE(NRI) Range Over the Past 10 Years
Min: 9.92  Med: 27.87 Max: 755.25
Current: 29.71
9.92
755.25
P/B 1.76
CNMD's P/B is ranked higher than
70% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. CNMD: 1.76 )
Ranked among companies with meaningful P/B only.
CNMD' s P/B Range Over the Past 10 Years
Min: 0.61  Med: 1.43 Max: 2.88
Current: 1.76
0.61
2.88
P/S 1.42
CNMD's P/S is ranked higher than
71% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 2.31 vs. CNMD: 1.42 )
Ranked among companies with meaningful P/S only.
CNMD' s P/S Range Over the Past 10 Years
Min: 0.48  Med: 1.10 Max: 2.29
Current: 1.42
0.48
2.29
PFCF 20.42
CNMD's PFCF is ranked higher than
77% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 32.20 vs. CNMD: 20.42 )
Ranked among companies with meaningful PFCF only.
CNMD' s PFCF Range Over the Past 10 Years
Min: 7.44  Med: 19.11 Max: 2046
Current: 20.42
7.44
2046
POCF 15.84
CNMD's POCF is ranked higher than
75% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 19.76 vs. CNMD: 15.84 )
Ranked among companies with meaningful POCF only.
CNMD' s POCF Range Over the Past 10 Years
Min: 6.18  Med: 13.13 Max: 138.5
Current: 15.84
6.18
138.5
EV-to-EBIT 21.92
CNMD's EV-to-EBIT is ranked higher than
60% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 27.37 vs. CNMD: 21.92 )
Ranked among companies with meaningful EV-to-EBIT only.
CNMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -197.2  Med: 19.40 Max: 224.4
Current: 21.92
-197.2
224.4
EV-to-EBITDA 12.18
CNMD's EV-to-EBITDA is ranked higher than
71% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 17.32 vs. CNMD: 12.18 )
Ranked among companies with meaningful EV-to-EBITDA only.
CNMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 12.20 Max: 42.4
Current: 12.18
5.5
42.4
PEG 2.45
CNMD's PEG is ranked higher than
57% of the 68 Companies
in the Global Medical Devices industry.

( Industry Median: 3.33 vs. CNMD: 2.45 )
Ranked among companies with meaningful PEG only.
CNMD' s PEG Range Over the Past 10 Years
Min: 1.39  Med: 5.54 Max: 1020.61
Current: 2.45
1.39
1020.61
Shiller P/E 40.38
CNMD's Shiller P/E is ranked lower than
61% of the 69 Companies
in the Global Medical Devices industry.

( Industry Median: 31.42 vs. CNMD: 40.38 )
Ranked among companies with meaningful Shiller P/E only.
CNMD' s Shiller P/E Range Over the Past 10 Years
Min: 10.35  Med: 26.62 Max: 65.96
Current: 40.38
10.35
65.96
Current Ratio 3.44
CNMD's Current Ratio is ranked higher than
62% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. CNMD: 3.44 )
Ranked among companies with meaningful Current Ratio only.
CNMD' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.48 Max: 12.38
Current: 3.44
1.37
12.38
Quick Ratio 1.99
CNMD's Quick Ratio is ranked higher than
50% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CNMD: 1.99 )
Ranked among companies with meaningful Quick Ratio only.
CNMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.54 Max: 8.38
Current: 1.99
0.48
8.38
Days Inventory 166.56
CNMD's Days Inventory is ranked lower than
59% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. CNMD: 166.56 )
Ranked among companies with meaningful Days Inventory only.
CNMD' s Days Inventory Range Over the Past 10 Years
Min: 156.01  Med: 165.88 Max: 177.86
Current: 166.56
156.01
177.86
Days Sales Outstanding 67.94
CNMD's Days Sales Outstanding is ranked higher than
54% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. CNMD: 67.94 )
Ranked among companies with meaningful Days Sales Outstanding only.
CNMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.39  Med: 64.98 Max: 74.33
Current: 67.94
42.39
74.33
Days Payable 34.17
CNMD's Days Payable is ranked lower than
77% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. CNMD: 34.17 )
Ranked among companies with meaningful Days Payable only.
CNMD' s Days Payable Range Over the Past 10 Years
Min: 22.06  Med: 27.69 Max: 45.71
Current: 34.17
22.06
45.71

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.18
CNMD's Dividend Yield is ranked higher than
69% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.72 vs. CNMD: 2.18 )
Ranked among companies with meaningful Dividend Yield only.
CNMD' s Dividend Yield Range Over the Past 10 Years
Min: 0.5  Med: 1.65 Max: 2.22
Current: 2.18
0.5
2.22
Dividend Payout 0.66
CNMD's Dividend Payout is ranked lower than
79% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. CNMD: 0.66 )
Ranked among companies with meaningful Dividend Payout only.
CNMD' s Dividend Payout Range Over the Past 10 Years
Min: 0.4  Med: 0.54 Max: 2.86
Current: 0.66
0.4
2.86
Forward Dividend Yield 2.17
CNMD's Forward Dividend Yield is ranked higher than
68% of the 176 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. CNMD: 2.17 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.18
CNMD's Yield on cost (5-Year) is ranked higher than
56% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. CNMD: 2.18 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CNMD' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.5  Med: 1.65 Max: 2.22
Current: 2.18
0.5
2.22
3-Year Average Share Buyback Ratio 1.00
CNMD's 3-Year Average Share Buyback Ratio is ranked higher than
90% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: -4.30 vs. CNMD: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CNMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -7.8  Med: -0.40 Max: 1.6
Current: 1
-7.8
1.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 61.97
CNMD's Price/Tangible Book is ranked lower than
99% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 4.33 vs. CNMD: 61.97 )
Ranked among companies with meaningful Price/Tangible Book only.
CNMD' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.46  Med: 6.77 Max: 315.56
Current: 61.97
2.46
315.56
Price/Projected FCF 1.06
CNMD's Price/Projected FCF is ranked higher than
84% of the 217 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. CNMD: 1.06 )
Ranked among companies with meaningful Price/Projected FCF only.
CNMD' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.5  Med: 1.00 Max: 1.74
Current: 1.06
0.5
1.74
Price/Median PS Value 1.28
CNMD's Price/Median PS Value is ranked lower than
67% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. CNMD: 1.28 )
Ranked among companies with meaningful Price/Median PS Value only.
CNMD' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.49  Med: 1.09 Max: 2.74
Current: 1.28
0.49
2.74
Price/Peter Lynch Fair Value 3.93
CNMD's Price/Peter Lynch Fair Value is ranked lower than
74% of the 70 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. CNMD: 3.93 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CNMD' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.38  Med: 1.65 Max: 104.57
Current: 3.93
0.38
104.57
Price/Graham Number 11.08
CNMD's Price/Graham Number is ranked lower than
94% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 2.88 vs. CNMD: 11.08 )
Ranked among companies with meaningful Price/Graham Number only.
CNMD' s Price/Graham Number Range Over the Past 10 Years
Min: 1.26  Med: 3.89 Max: 183
Current: 11.08
1.26
183
Earnings Yield (Greenblatt) (%) 4.58
CNMD's Earnings Yield (Greenblatt) (%) is ranked higher than
76% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. CNMD: 4.58 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CNMD' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.4  Med: 5.00 Max: 12.6
Current: 4.58
0.4
12.6
Forward Rate of Return (Yacktman) (%) 13.56
CNMD's Forward Rate of Return (Yacktman) (%) is ranked higher than
78% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. CNMD: 13.56 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CNMD' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -13.3  Med: 4.45 Max: 19.3
Current: 13.56
-13.3
19.3

More Statistics

Revenue(Mil) $719
EPS $ 1.23
Beta0.88
Short Percentage of Float4.96%
52-Week Range $35.53 - 60.66
Shares Outstanding(Mil)27.70

Analyst Estimate

Dec16 Dec17
Revenue(Mil) 764 819
EPS($) 1.43 1.67
EPS without NRI($) 1.43 1.67

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:EC8.Germany,
Conmed Corp was incorporated under the laws of the State of New York in 1970. It is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians in a variety of specialties including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. Effective January 1, 2013, the Company is accounting and reporting business as a single segment entity engaged in the development, manufacturing and sale on a basis of surgical devices and related equipment. The business is derived from sales in orthopedic surgery product lines, including sports medicine, powered surgical instruments and sports biologics and tissue. These lines are marketed under a number of reputable brands, including Hall, CONMED Linvatec, Concept and Shutt. The surgical visualization product line offers endoscopic imaging and capture devices for the complete spectrum of surgical needs including 2DHD and 3DHD vision technologies. The general surgery product line offers in the areas of advanced energy, endomechanical instrumentation, gastrointestinal, pulmonary and patient monitoring. The products are distributed domestically directly to more than 6,000 hospitals and other healthcare institutions as well as through medical specialty distributors and surgeons. The operation of Company are subject, to a number of environmental laws and regulations governing, among other things, air emissions, wastewater discharges, the use, handling and disposal of hazardous substances and wastes, soil and groundwater remediation and employee health and safety.
» More Articles for CNMD

Headlines

Articles On GuruFocus.com
Activist Hedge Fund Manager Jerome Lande Buys Stake in Technology Company Sep 25 2015 
Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 
Weekly CEO Sells Highlight: Profire energy Inc, Graphic Packaging Holding Co, Seagate Technology PLC Aug 04 2014 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
CONMED Corp. (CNMD) Vice President/Finance/CFO Robert D Jr Shallish sells 6,151 Shares Feb 07 2011 
CONMED Corp. Reports Operating Results (10-Q) Nov 02 2010 
CONMED Corp. Reports Operating Results (10-Q) Aug 03 2010 
CONMED Corp. Reports Operating Results (10-Q) May 05 2010 
CONMED Corp. (CNMD) President & CEO Joseph J Corasanti sells 37,501 Shares Dec 15 2009 

More From Other Websites
CONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference Feb 01 2016
CONMED Corporation to Present at the LEERINK Partners 5th Annual Global Healthcare Conference Feb 01 2016
CONMED Corp. Earnings Analysis: Q4, 2015 By the Numbers Jan 29 2016
CONMED Beats Q4 Earnings & Sales, FY16 View Impressive Jan 28 2016
Edited Transcript of CNMD earnings conference call or presentation 27-Jan-16 9:30pm GMT Jan 28 2016
CONMED CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jan 27 2016
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results Jan 27 2016
Conmed Corp Earnings Call scheduled for 4:30 pm ET today Jan 27 2016
CONMED Corporation Announces Fourth Quarter and Fiscal Year 2015 Financial Results Jan 27 2016
Q4 2015 Conmed Corp Earnings Release - After Market Close Jan 27 2016
CONMED Corporation to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on January 27,... Jan 15 2016
CONMED Corporation to Announce Fourth Quarter and Fiscal Year 2015 Financial Results on January 27,... Jan 15 2016
CONMED Corp. breached its 50 day moving average in a Bearish Manner : January 8, 2016 Jan 08 2016
CONMED (CNMD) Seals SurgiQuest Buy, Boosts Surgical Unit Jan 05 2016
CONMED CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a... Jan 04 2016
CONMED Completes Acquisition of SurgiQuest, Inc. Jan 04 2016
CONMED Completes Acquisition of SurgiQuest, Inc. Jan 04 2016
CONMED Corp. breached its 50 day moving average in a Bullish Manner : December 23, 2015 Dec 23 2015
CONMED Corporation to Present at the Annual J.P. Morgan Healthcare Conference Dec 17 2015
CONMED Corporation to Present at the Annual J.P. Morgan Healthcare Conference Dec 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK